Could Ebola vaccine delay be due to an intellectual property spat?
Friday, October 3, 2014 - 04:20
in Biology & Nature
Questions remain over why a made-in-Canada experimental Ebola vaccine is still sitting in a Winnipeg laboratory instead of being dispensed in West Africa, with a scientific journal suggesting an intellectual property dispute may be to blame.